07:23:39 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



New Research: Key Drivers of Growth for SpartanNash, Nustar GP, Hornbeck Offshore Services, TiVo, Eli Lilly, and Rigel Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production

2018-02-21 07:30 ET - News Release

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SpartanNash Company (NASDAQ:SPTN), Nustar GP Holdings, LLC (NYSE:NSH), Hornbeck Offshore Services (NYSE:HOS), TiVo Corporation (NASDAQ:TIVO), Eli Lilly and Company (NYSE:LLY), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SPTN DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPTN
NSH DOWNLOAD:
http://Fundamental-Markets.com/register/?so=NSH
HOS DOWNLOAD:
http://Fundamental-Markets.com/register/?so=HOS
TIVO DOWNLOAD:
http://Fundamental-Markets.com/register/?so=TIVO
LLY DOWNLOAD:
http://Fundamental-Markets.com/register/?so=LLY
RIGL DOWNLOAD:
http://Fundamental-Markets.com/register/?so=RIGL

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine SpartanNash Company (NASDAQ:SPTN), Nustar GP Holdings, LLC (NYSE:NSH), Hornbeck Offshore Services (NYSE:HOS), TiVo Corporation (NASDAQ:TIVO), Eli Lilly and Company (NYSE:LLY), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

SPARTANNASH COMPANY (SPTN) REPORT OVERVIEW

SpartanNash's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, SpartanNash reported revenue of $1,906.64MM vs $1,800.09MM (up 5.92%) and basic earnings per share -$3.32 vs $0.44. For the twelve months ended December 31st, 2016 vs December 31st, 2015, SpartanNash reported revenue of $7,734.60MM vs $7,651.97MM (up 1.08%) and basic earnings per share $1.52 vs $1.67 (down 8.98%). SpartanNash is expected to report earnings on February 21st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.53. The estimated EPS forecast for the next fiscal year is $2.18 and is expected to report on February 21st, 2018.

To read the full SpartanNash Company (SPTN) report, download it here: http://Fundamental-Markets.com/register/?so=SPTN

-----------------------------------------

NUSTAR GP HOLDINGS, LLC (NSH) REPORT OVERVIEW

Nustar GP's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Nustar GP reported revenue of $12.18MM vs $16.13MM (down 24.51%) and basic earnings per share $0.26 vs $0.40 (down 35.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Nustar GP reported revenue of $56.10MM vs $79.67MM (down 29.59%) and basic earnings per share $1.28 vs $1.68 (down 23.81%). Nustar GP is expected to report earnings on April 23rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.39. The estimated EPS forecast for the next fiscal year is $1.62 and is expected to report on February 14th, 2019.

To read the full Nustar GP Holdings, LLC (NSH) report, download it here: http://Fundamental-Markets.com/register/?so=NSH

-----------------------------------------

HORNBECK OFFSHORE SERVICES (HOS) REPORT OVERVIEW

Hornbeck Offshore Services' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Hornbeck Offshore Services reported revenue of $56.24MM vs $41.88MM (up 34.29%) and basic earnings per share $2.53 vs -$0.53. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Hornbeck Offshore Services reported revenue of $191.41MM vs $224.30MM (down 14.66%) and basic earnings per share $0.74 vs -$1.76. Hornbeck Offshore Services is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.76. The estimated EPS forecast for the next fiscal year is -$2.26 and is expected to report on February 6th, 2019.

To read the full Hornbeck Offshore Services (HOS) report, download it here: http://Fundamental-Markets.com/register/?so=HOS

-----------------------------------------

TIVO CORPORATION (TIVO) REPORT OVERVIEW

TiVo's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, TiVo reported revenue of $197.90MM vs $153.12MM (up 29.24%) and basic earnings per share -$0.14 vs $0.55. For the twelve months ended December 31st, 2016 vs December 31st, 2015, TiVo reported revenue of $649.09MM vs $526.27MM (up 23.34%) and basic earnings per share $0.35 vs -$0.05. TiVo is expected to report earnings on February 27th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.36. The estimated EPS forecast for the next fiscal year is $1.27 and is expected to report on February 27th, 2018.

To read the full TiVo Corporation (TIVO) report, download it here: http://Fundamental-Markets.com/register/?so=TIVO

-----------------------------------------

ELI LILLY AND COMPANY (LLY) REPORT OVERVIEW

Eli Lilly's Recent Financial Performance

Eli Lilly is expected to report earnings on April 24th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.98. The estimated EPS forecast for the next fiscal year is $5.26 and is expected to report on January 30th, 2019.

To read the full Eli Lilly and Company (LLY) report, download it here: http://Fundamental-Markets.com/register/?so=LLY

-----------------------------------------

RIGEL PHARMACEUTICALS, INC. (RIGL) REPORT OVERVIEW

Rigel Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Rigel Pharmaceuticals reported revenue of $0.90MM vs $3.76MM (down 76.06%) and basic earnings per share -$0.14 vs -$0.24. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Rigel Pharmaceuticals reported revenue of $20.38MM vs $28.90MM (down 29.46%) and basic earnings per share -$0.73 vs -$0.58. Rigel Pharmaceuticals is expected to report earnings on March 6th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.53 and is expected to report on March 6th, 2018.

To read the full Rigel Pharmaceuticals, Inc. (RIGL) report, download it here: http://Fundamental-Markets.com/register/?so=RIGL

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

© 2024 Canjex Publishing Ltd. All rights reserved.